• Atyr PHARMA (NASDAQ:ATYR) Earns Outperform Rating from Analysts at Leerink Partners

    Source: Buzz FX / 19 Feb 2025 08:01:12   America/New_York


    Atyr PHARMA (NASDAQ:ATYR) Earns Outperform Rating from Analysts at Leerink Partners Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Research analysts at Leerink Partners assumed coverage on shares of Atyr PHARMA ( NA
    Read more...
Share on,